Kohei Inoue

Kohei Inoue is a staff writer of the Sankei Shimbun.

COVID-19 Oral Treatment Drug Shionogi

Will the Next Oral COVID-19 Drug Come from Japan?

Naomi Yasuda March 24, 2022

Japanese drugmaker Shionogi & Co. looks to meet domestic demand, as countries worldwide scramble...

JF iPS

Japan Needs Better Research Investment to Protect its Discoveries in iPS Cell Treatment

Kohei Inoue March 17, 2022

iPS cells bring hope for treatment of neurodegenerative diseases such as Parkinson’s, but China...